Nemluvio Shows Three-Year Durability in Atopic Dermatitis
Galderma presented three-year Nemluvio® data at Fall Clinical 2026 showing deep, lasting lesion and itch responses in atopic dermatitis patients aged 12 and older.
Topic
Nemluvio
Topic
Nemluvio
Nemluvio Shows Durable Three-Year Responses in Atopic Dermatitis
At Fall Clinical 2026, Galderma presented three-year Nemluvio data showing deep, lasting skin lesion and itch responses in atopic…
Galderma Presents New Nemluvio Data in Atopic Dermatitis Aged 12+
Galderma has presented new Nemluvio (nemolizumab) data showing responses in patients with atopic dermatitis aged 12 and older, ad…